Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
220 participants
OBSERVATIONAL
2025-04-01
2029-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low Dose Catheter Directed Thrombolysis for Acute Pulmonary Embolism
NCT03854266
Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
NCT04088292
Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients
NCT06487052
'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL
NCT06833827
Pulmonary Embolism International THrOmbolysis Study-3
NCT04430569
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are several ongoing trials comparing different CDI methods to anticoagulation. However, in clinical practice, patients with acute PE may be subjected to different reperfusion strategies depending on severity and available resources. The PE-NORDIC observational study will compare the outcomes of different patient groups treated with current CDI methods used in the Nordic countries to patients treated with ST.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Catheter-directed intervention
Catheter-directed intervention, any device
Catheter directed intervention, any device
Catheter directed intervention for treatment of pulmonary embolism
Systemic thrombolysis
Intravenous thrombolysis with tissue-type plasminogen activator (tPA)
Alteplase
Systemic thrombolysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Catheter directed intervention, any device
Catheter directed intervention for treatment of pulmonary embolism
Alteplase
Systemic thrombolysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent (for patients who do not survive before informed consent can be obtained, a waiver of consent applies)
Exclusion Criteria
* Surgical embolectomy as primary reperfusion treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stockholm South General Hospital
OTHER
Karolinska University Hospital
OTHER
Danderyd Hospital
OTHER
University Hospital, Linkoeping
OTHER
Sunderby Hospital
OTHER
Aarhus University Hospital
OTHER
Örebro University, Sweden
OTHER
Odense University Hospital
OTHER
Skane University Hospital
OTHER
Rigshospitalet, Denmark
OTHER
Sahlgrenska University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristina Svennerholm
Principal investigator. MD. PhD.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristina Svennerholm, Assoc Prof
Role: PRINCIPAL_INVESTIGATOR
Sahlgrenska University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aarhus University Hospital
Aarhus, , Denmark
Rigshospitalet
Copenhagen, , Denmark
Odense University Hospital
Odense, , Denmark
Sahlgrenska University Hospital
Gothenburg, , Sweden
Linköping University Hospital
Linköping, , Sweden
Sunderby Hospital
Luleå, , Sweden
Skåne University Hospital
Lund, , Sweden
Örebro University Hospital
Örebro, , Sweden
Danderyd Hospital
Stockholm, , Sweden
Karolinska University Hospital Huddinge
Stockholm, , Sweden
Karolinska University Hospital Solna
Stockholm, , Sweden
Södersjukhuset
Stockholm, , Sweden
Uppsala University Hospital
Uppsala, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PE-NORDIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.